Biochemical testing for neuroendocrine tumors.

Area of Science:

• Oncology
• Biochemistry
• Medical Diagnostics

Background:

• Neuroendocrine tumors (NETs) present diagnostic challenges.
• Biochemical markers are crucial for NET diagnosis and management.
• Existing literature often focuses narrowly on specific tumor types.

Purpose of the Study:

• To provide a comprehensive overview of biochemical markers for NET diagnosis and differential diagnosis.
• To introduce a novel, integrated approach for utilizing biochemical markers throughout the patient journey.
• To guide therapeutic decision-making and prognosis assessment using biochemical data.

Main Methods:

• Review of existing literature on biochemical markers for NETs.
• Synthesis of information on markers related to symptoms, diagnosis, and prognosis.
• Development of an algorithmic approach for marker utilization.

Main Results:

• Biochemical markers aid in diagnosing NETs and excluding mimicking conditions.
• Markers are valuable for monitoring treatment response and patient prognosis.
• A novel approach integrates symptom-based markers with diagnostic and therapeutic decision-making markers.

Conclusions:

• Biochemical markers are indispensable tools in the multidisciplinary management of neuroendocrine tumors.
• The proposed integrated approach enhances diagnostic accuracy and optimizes therapeutic strategies.
• Understanding marker properties is key to managing NETs and their complications like bone metastasis and carcinoid heart disease.